Xuyong Wei
Overview
Explore the profile of Xuyong Wei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
109
Citations
1021
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
51.
Su R, Zhang H, Zhang L, Khan A, Zhang X, Wang R, et al.
Cancer Med
. 2022 Dec;
12(7):8937-8955.
PMID: 36524545
Background: Microvascular invasion (MVI) is an independent detrimental risk factor for tumor recurrence and poor survival in hepatocellular carcinoma (HCC). Competitive endogenous RNA (ceRNA) networks play a pivotal role in...
52.
Lu D, Lin Z, Wang R, Chen Z, Zhuo J, Xu L, et al.
Redox Biol
. 2022 Nov;
58:102538.
PMID: 36417796
Sarcopenia is prevalent in patients with hepatocellular carcinoma (HCC), and can adversely affect their outcomes. This study aims to explore the key mechanisms in the crosstalk between sarcopenia and HCC...
53.
Wei X, Xie W, Yin W, Yang M, Khan A, Su R, et al.
Am J Cancer Res
. 2022 Oct;
12(9):4160-4176.
PMID: 36225628
Recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT) is a marker of poor prognosis. However, the reliable biomarkers of post-LT HCC recurrence remain to be identified. In this study,...
54.
He C, Lu D, Lin Z, Chen H, Li H, Yang X, et al.
Stem Cell Rev Rep
. 2022 Oct;
19(2):345-357.
PMID: 36199007
The past decades have witnessed great advances in organoid technology. Liver is the biggest solid organ, performing multifaceted physiological functions. Nowadays, liver organoids have been applied in many fields including...
55.
Xiang Z, Li J, Lu D, Wei X, Xu X
Front Microbiol
. 2022 Sep;
13:987324.
PMID: 36118247
Viral hepatitis is a major global public health problem that affects hundreds of millions of people and is associated with significant morbidity and mortality. Five biologically unrelated hepatotropic viruses account...
56.
Tang L, Wei R, Chen R, Fan G, Zhou J, Qi Z, et al.
Comput Struct Biotechnol J
. 2022 Sep;
20:4402-4414.
PMID: 36051877
Hepatocellular carcinoma (HCC) represents the most important type of liver cancer, the 5-year survival rate for advanced HCC is 2%. The heterogeneity of HCC makes previous models fail to achieve...
57.
Shu W, Yang M, Yang J, Lin S, Wei X, Xu X
Cell Commun Signal
. 2022 Aug;
20(1):117.
PMID: 35941604
The liver is unique in its ability to regenerate from a wide range of injuries and diseases. Liver regeneration centers around hepatocyte proliferation and requires the coordinated actions of nonparenchymal...
58.
Ling S, Zhan Q, Jiang G, Shan Q, Yin L, Wang R, et al.
Am J Transplant
. 2022 Jun;
22(10):2323-2336.
PMID: 35729702
The mammalian target of rapamycin (mTOR) pathway is frequently deregulated and has critical roles in cancer progression. mTOR inhibitor has been widely used in several kinds of cancers and is...
59.
Wei X, Pan B, Yang M, Shu W, Khan A, Su R, et al.
Technol Cancer Res Treat
. 2022 Jun;
21:15330338221106820.
PMID: 35722791
Chloride intracellular channel 1 (CLIC1) is upregulated in hepatocellular carcinoma (HCC). The present study aimed to investigate the role of CLIC1 in HCC angiogenesis. Immunohistochemistry (IHC) was used to test...
60.
Su R, Wei X, Wei Q, Lu D, Lin Z, Wang S, et al.
Hepatobiliary Surg Nutr
. 2022 Jun;
11(3):400-411.
PMID: 35693397
Background And Objective: Non-alcoholic fatty liver disease (NAFLD) is highly prevalent in patients who undergo liver transplantation (LT). Whereas there is huge data on NAFLD, little is known about NAFLD...